Interview: Eduardo Loyola, General Manager, Heel, Chile
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Address: Santa Clara 301, Oficina 6805, Huechuraba, Santiago,Chile
Tel: +56 2 368 2700
Web: http://www.grupobago.com/farmaceutica.asp
Laboratorio Bago de Chile in its 60 years, occupies a leading position within the Chilean pharmaceutical market, both in units and values, ranking among the five largest companies in the Chilean pharmaceutical sector. Laboratorio Bago Chile is a member and part of the greater Bagó Organization and it serves as the regional headquarters for the Andean region. They had annual sales of US$32 million last year.
Bago’s Pharmaceuticals is certified by the Public Health Institute of Chile in the strict GMP (Good Manufacturing Practice) in accordance with manufacturing practices recommended by the World Health Organization. It produces 20,000,000 units annually for the local market (40%) and the rest for export to Bolivia, Ecuador, Paraguay and Peru. Their product line includes 86 branded products in a wide range of dosage forms, totaling 165 presentations.
Research and Development
Eduardo Loyola has been at the helm of Heel’s Chilean affiliate for almost a decade. Prior to his appointment at Heel, Loyola was part of a working group that is…
Medtronic, world’s largest medical technology company, opened a direct operation in Chile in October 2013. Gonzalo Valdebenito elaborates on the affiliate’s first steps in the country and the mission he…
Cells for Cells is the first Chilean biotechnology company engaged in the research, development and commercialization of innovative cell therapies based on adult stem cells. In line with the company’s…
“We have implemented a strategic plan with a key objective to put Chile on the map. We are seeing major market opportunities in the country”, says Carlos Cicogna, Managing Director,…
Ciro Caravaggio, General Manager at Roche Chile discusses Roche’s mission as a highly specialized biotech with a long presence in Chile. He stresses the importance of the affiliate’s role in…
Raúl Sánchez, general manager of Peri Logistics speaks about the main features that distinguish Peri Logistics as a pharmaceutical logistics operator. Celebrating its 10th year anniversary this year, the company…
João Simões, Head of Integration at Grunenthal Chile, discusses Grunenthal’s acquisition of Andrómaco Laboratories. The acquisition has been a major step in Grunenthal’s growth strategy and has almost doubled its…
“70 percent of products on the Chilean market cannot demonstrate quality, safety and efficacy through bioequivalence studies”, explains Jean Jacques Duhart, Vicepresidente Ejecutivo of the association that represents the innovative…
Rodrigo Azócar Ibaceta, general manager at Laboratorios Raffo Chile speaks about Raffo’s development on the Chilean market. Part of the prestigious GP Pharm’s group, Raffo is one of the fastest…
Erich Viertel Molina, country manager at Janssen Chile speaks about Janssen’s commitment to the health of Chileans. Over the past years Janssen successfully launched several products to the Chilean market…
Pfizer will invest in a precision medical center studying new genome-based diagnostic technologies for cancer in Chile. It is the first center of excellence that Pfizer is building in Chile…
Our business model is new in the Chilean market and enables us with great flexibility and allows us to focus on demand generation. For Ferrer this is a great window…
See our Cookie Privacy Policy Here